Mirtazapine-Induced Thrombocytopenia and Neutropenia

Journal Title: Turkish Journal of Hematology - Year 2012, Vol 29, Issue 3

Abstract

To the Editor, Neutropenia is a rare and commonly reversible sideeffect of antidepressant treatment [1]. Mirtazapine is a noradrenergic and specific serotonergic antidepressant that is approved for use in the treatment of major depression in many countries [2]. A major hematological side effect of mirtazapine is agranulocytosis. Herein we report a patient with depression that developed severe neutropenia-associated thrombocytopenia during treatment with mirtazapine; the patient was safely treated by switching to another drug.

Authors and Affiliations

Selami Toprak, Elçin Erdogan, Özlem Azap

Keywords

Related Articles

Hb D-Los Angeles [beta121(GH4)Glu>Gln] and Hb Beograd [beta121(GH4)Glu>Val]: Implications for their laboratory diagnosis and genetic origins

Objective: The aim of this study was to determine the laboratory diagnosis and genetic origins of the hemoglobin (Hb) variants, Hb D-Los Angeles and Hb Beograd observed frequently in our region. Material and Methods: Hb...

Niemann - Pick disease associated with hemophagocytic syndrome

Hemophagocytic lymphohistiocytosis (HLH) is a disease characterized by phagocytosis of blood cells by macrophages within the lymphoreticular tissue. It can develop secondary to some diseases or be familial as a result of...

Download PDF file
  • EP ID EP116634
  • DOI 10.5505/tjh.2012.72325
  • Views 94
  • Downloads 0

How To Cite

Selami Toprak, Elçin Erdogan, Özlem Azap (2012). Mirtazapine-Induced Thrombocytopenia and Neutropenia. Turkish Journal of Hematology, 29(3), 297-298. https://europub.co.uk/articles/-A-116634